Related Experiment Video
Updated: Jul 29, 2025

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells
Published on: November 11, 2021
EIF4A3-Induced Exosomal circLRRC8A Alleviates Granulosa Cells Senescence Via the miR-125a-3p/NFE2L1 axis
Jie Xing1,2, Mengxue Zhang1,2, Shijie Zhao1,2
1Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Abstract:
Premature ovarian failure (POF) is an important cause of female infertility and seriously impacts the physical and psychological health of patients. Mesenchymal stromal cells-derived exosomes (MSCs-Exos) have an essential role in the treatment of reproductive disorders, particularly POF. However, the biological function and therapeutic mechanism of MSCs exosomal circRNAs in POF remain to be determined. Here, with bioinformatics analysis and functional assays, circLRRC8A was found to be downregulated in senescent granulosa cells (GCs) and acted as a crucial factor in MSCs-Exos for oxidative damage protection and anti-senescence of GCs in vitro and in vivo. Mechanistic investigations revealed that circLRRC8A served as an endogenous miR-125a-3p sponge to downregulate NFE2L1 expression. Moreover, eukaryotic initiation factor 4A3 (EIF4A3), acting as a pre-mRNA splicing factor, promoted circLRRC8A cyclization and expression by directly binding to the LRRC8A mRNA transcript. Notably, EIF4A3 silencing reduced circLRRC8A expression and attenuated the therapeutic effect of MSCs-Exos on oxidatively damaged GCs. This study demonstrates a new therapeutic pathway for cellular senescence protection against oxidative damage by delivering circLRRC8A-enriched exosomes through the circLRRC8A/miR-125a-3p/NFE2L1 axis and paves the way for the establishment of a cell-free therapeutic approach for POF. CircLRRC8A may be a promising circulating biomarker for diagnosis and prognosis and an exceptional candidate for further therapeutic exploration.
Insights
Mesenchymal stromal cell exosomes carrying circLRRC8A protect against premature ovarian failure by reducing cellular senescence. This discovery offers a new cell-free therapy for POF and identifies circLRRC8A as a potential diagnostic biomarker.
Area of Science:
- Reproductive Biology
- Cellular Senescence
- Exosome Biology
Background:
- Premature ovarian failure (POF) causes infertility and impacts women's health.
- Mesenchymal stromal cells-derived exosomes (MSCs-Exos) show therapeutic potential for POF.
- The role of exosomal circRNAs in MSCs-Exos for POF treatment is unclear.
Purpose of the Study:
- To investigate the function and mechanism of circLRRC8A in MSCs-Exos for treating POF.
- To explore circLRRC8A's role in protecting granulosa cells (GCs) from oxidative damage and senescence.
- To elucidate the molecular pathway involving circLRRC8A in POF.
Main Methods:
- Bioinformatics analysis and functional assays.
- In vitro and in vivo experiments on senescent granulosa cells.
- Investigation of the circLRRC8A/miR-125a-3p/NFE2L1 axis and EIF4A3's role in circLRRC8A expression.
Main Results:
- circLRRC8A was downregulated in senescent GCs and protected them from oxidative damage and senescence.
- circLRRC8A acted as a miR-125a-3p sponge, downregulating NFE2L1.
- Eukaryotic initiation factor 4A3 (EIF4A3) promoted circLRRC8A expression by binding to LRRC8A mRNA.
Conclusions:
- MSCs-Exos enriched with circLRRC8A offer a novel cell-free therapeutic strategy for POF by targeting the circLRRC8A/miR-125a-3p/NFE2L1 pathway.
- circLRRC8A demonstrates potential as a biomarker for POF diagnosis and prognosis.
- This study establishes a new therapeutic avenue for combating cellular senescence and oxidative damage in POF.
Related Concept Videos
The Nucleolus
Mitogens and the Cell Cycle

